Trend in implantable cardioverter defibrillators and relation to need

Journal of Cardiovascular Medicine

Volumn 11, Issue 4, 2010, Pages 265-270

  Giammaria, Massimo ^a   Bruna, Claudio ^b   Gnavi, Roberto ^c  

^a MARIA VITTORIA HOSPITAL   (Italy)

^b Mondovì Hospital   (Italy)

^c ASL TO3   (Italy)

Author keywords

Defibrillators; Delivery of healthcare; Gender; Health services needs and demand; Implantable

Indexed keywords

BISOPROLOL; CARVEDILOL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; GEOGRAPHIC DISTRIBUTION; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; SEX RATIO;

ADULT; AGED; AGED, 80 AND OVER; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; ITALY; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77949433078     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283356693     Document Type: Article

References (32)

1. The Network Devices Survey Group. Pacemakers and implantable defibrillators: a two year national survey for 2003 and 2004. Network Devices Survey Group, 2006. http://www.devicesurvey.com. [Accessed 8 December 2009].
2. Kearney P, Stokoe G, Breithardt G, Longson C, Marco J, Morgan J, et al. Improving patient access to novel medical technologies in Europe. Eur Heart J 2006; 27:882-885.
3. Groeneveld PW, Heidenerich PA, Garber AM. Trends in implantable cardioverter-defibrillator racial disparity. J AmCollCardiol 2005; 45:72-78.
4. Proclemer A, Ghidina M, Gregori D, Facchin D, Rebellato L, Fioretti P, Brignole M. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-2007. Europace 2009; 11:465-475.
5. Lin G, Meverden RA, Hodge DO, Uslan DZ, Hayes DL, Brady PA. Age and gender trends in implantable cardioverter defibrillator utilization: a population based study. J Interv Card Electrophysiol 2008; 22:65-70.
6. Cunningham AD, Plummer CJ, McComb JM, Lord SW, Cunningham MW, Toussaint JM, Rickards AF. The implantable cardioverter-defibrillator: postcode prescribing in the UK 1998-2002. Heart 2005; 91:1280-1283.
7. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial II. Prophylactic implantation of defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883.
8. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10:933-989.
9. Plummer CJ, Irving RJ, MC Comb JM. The incidence of implantable cardioverter defibrillator indications in patients admitted to all coronary care units in a single district. Europace 2005; 7:266-272.
10. Scott PA, Gorman S, Andrews NP, Roberts PR, Kaira PR. Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death postmyocardial infarction based on UK national guidelines (2006). Europace 2008; 10:453-457.
11. Parkes J, Chase DL, Grace A, Cunningham D, Roderick PJ. Inequity of use of implantable cardioverter defibrillators in England: retrospective analysis. BMJ 2005; 330:454-4555.
12. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48:e247-e346.
13. Scholte op Reimer WJM, Simoons ML, Boersma E, Gitt AK, editors. Cardiovascular diseases in Europe. Euro Heart Survey 2006. Sophia Antipolis: European Society of Cardiology 2006. http://www.escardio.org/ guidelines-surveys/ehs/Documents/EHS-CVD-report-2006.pdf. [Accessed 8 December 2009].
14. Udell JA, Juurlink DN, Kopp A, Lee DS, Tu JV, Mamdani MM. Inequitable distribution of implantable cardioverter defibrillators in Ontario. Int J Technol Assess Healthcare 2007; 23:354-361.
15. Thomas KL, Al-Khatib SM, Kelsey RC II, Bush H, Brosius L, Velazquez EJ, et al. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of-35%. Am J Cardiol 2007; 100:924-929.
16. Fitch-Warner K, Garcia de Yébenes MJ, Lazaro y de Mercado P, Belaza- Santurde J. Variations among Spanish regions in the use of three cardiovascular technologies. Rev Esp Cardiol 2006; 59:1232-1243.
17. http://www.istat.it/sanita/Health/. [Accessed 24 November 2009].
18. Scott PA, Nicholas GT, Chung A, Morgan JM, Roberts P. Varying implantable cardioverter defibrillator referral patterns from implanting and nonimplanting hospitals. Europace 2009; 11:1048-1051.
19. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335:1933-1940.
20. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter: defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-237.
21. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350:2140-2150.
22. Barker WH, Mullooly JP, Getchell W. Changing incidence and survival for heart failure in a well defined older population, 1970-1974 and 1990-1994. Circulation 2006; 113:799-805.
23. Anselmino M, Petrelli A, Gnavi R, Bobbio M, Trevi G. Hospital admissions for congestive heart failure in Piedmont, Italy: 2001 trend. Ital Heart J Suppl 2005; 6:42-52.
24. Radovanovic D, Erne P, Urban P, Bertel O, Rickli H, Gaspoz JM, on behalf of the AMIS Plus Investigators. Sex differences in management and outcomes in patients with acute coronary syndromes: results on 290 patients from the AMIS Plus Registry. Heart 2007; 93: 1369-1375.
25. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbility and mortality in patients with chronic heart failure. N Engl J Med 1996; 334:1349-1355.
26. CIBIS II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999; 353:9-13.
27. Israel CW. Do some implant too many defibrillators or others too few? Europace 2009; 11:982-984.
28. Williams R, Wright J. Health needs assessment: epidemiological issues in health needs assessment. BMJ 1998; 316:1379-1382.
29. Ward PR, Noyce PR, St Leger AS. Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England. J Epidemiol Community Health 2004; 58:89-96.
30. Payne N, Saul C. Variations in use of cardiology services in a health authority: comparison of coronary artery revascularisation rates with prevalence of angina and coronary mortality. BMJ 1997; 314:257-261.
31. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 2006; 295:809-818.
32. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009; 131:149-150.